ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.751,28
2,32%
Brent Oil
83,76
0,67%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Edge Therapeutics, Inc. (EDGE)

  7. Edge Therapeutics, Inc. (EDGE) Notícias

EDGE

EDGE THERAPEUTICS, INC. (EDGE)

Edge Therapeutics, Inc.
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EDGE
DataHoraFonteTítuloCódigoCompanhia
18/03/201919:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201908:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
04/03/201919:30Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
22/02/201919:23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201918:21Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201908:15GlobeNewswire Inc.Edge Therapeutics Announces Full Year 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
15/02/201917:35Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:EDGEEdge Therapeutics, Inc.
15/02/201909:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EDGEEdge Therapeutics, Inc.
13/02/201914:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EDGEEdge Therapeutics, Inc.
25/01/201920:31Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:EDGEEdge Therapeutics, Inc.
03/01/201911:10Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:EDGEEdge Therapeutics, Inc.
21/12/201809:05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:EDGEEdge Therapeutics, Inc.
30/11/201812:39GlobeNewswire Inc.Edison issues update on NetScientific (NSCI)NASDAQ:EDGEEdge Therapeutics, Inc.
26/11/201809:30GlobeNewswire Inc.Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy CompanyNASDAQ:EDGEEdge Therapeutics, Inc.
01/11/201808:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EDGEEdge Therapeutics, Inc.
01/11/201807:00GlobeNewswire Inc.Edge Therapeutics Reports Third Quarter 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
01/08/201807:00GlobeNewswire Inc.Edge Therapeutics Reports Second Quarter 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
27/06/201817:30GlobeNewswire Inc.Edge Therapeutics Announces Updated Results from Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid HemorrhageNASDAQ:EDGEEdge Therapeutics, Inc.
20/06/201817:47Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:EDGEEdge Therapeutics, Inc.
11/06/201817:03Business WireDEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. &...NASDAQ:EDGEEdge Therapeutics, Inc.
06/06/201813:47Business WireSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. ...NASDAQ:EDGEEdge Therapeutics, Inc.
02/05/201810:33GlobeNewswire Inc.Edge Therapeutics Reports First Quarter 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
02/05/201810:33GlobeNewswire Inc.Edge Therapeutics Announces Review of Strategic AlternativesNASDAQ:EDGEEdge Therapeutics, Inc.
02/05/201810:06GlobeNewswire Inc.Edge Shareholders: Bernstein Liebhard LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Edge Therapeut...NASDAQ:EDGEEdge Therapeutics, Inc.
25/04/201817:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EDGEEdge Therapeutics, Inc.
25/04/201817:33Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EDGEEdge Therapeutics, Inc.
25/04/201814:33PR Newswire (US)Edge Shareholder Alert: Bernstein Liebhard LLP Announces That A Class Action Lawsuit Has Been Filed Against Edge Therapeutics...NASDAQ:EDGEEdge Therapeutics, Inc.
24/04/201816:27Business WireINVESTOR ALERT: Kirby McInerney LLP Announces a Securities Class Action on Behalf of Edge Therapeutics, Inc. InvestorsNASDAQ:EDGEEdge Therapeutics, Inc.
29/03/201810:34PR Newswire (US)Investor Alert: Kaplan Fox Announces Investigation Of Edge Therapeutics, Inc.NASDAQ:EDGEEdge Therapeutics, Inc.
28/03/201808:00GlobeNewswire Inc.Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid ...NASDAQ:EDGEEdge Therapeutics, Inc.
 Apresentando as notícias mais relevantes sobre:NASDAQ:EDGE

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GFSA3
GAFISA ON
BOV
HBOR3
HELBOR ON
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
TPIS3
TRIUNFO PART ON
BOV
ENAT3
ENAUTA ON
BOV
AMAR3
LOJAS MARISA ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
MEAL3
IMC S/A ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
PDTC3
Padtec ON
BOV
AZEV4
AZEVEDO PN
BOV
OPCT3
Oceanpact Servicos Marit... ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados